Anti-inflammatory eating is real and evidence-based. But the social media version has become something else. Here is what the research actually recommends.
“Inflammation” has become the explanation for everything — bloating, fatigue, weight that will not shift, skin that misbehaves. That is unfortunate, because chronic low-grade inflammation is a genuine, measurable process with a serious evidence base behind it, and the version circulating online has almost nothing to do with it. The distinction matters, because one of these leads to a reasonable diet and the other leads to eliminating tomatoes.
Inflammation is a real target, and here is how we know
The strongest proof that chronic inflammation causes disease rather than merely accompanying it does not come from nutrition research. It comes from drug trials.
A large randomised trial published in 2017 tested a monoclonal antibody targeting a specific inflammatory signalling molecule in patients who had already had a heart attack. It reduced cardiovascular events — and it did so without changing cholesterol at all. Subsequent trials of colchicine, an old anti-inflammatory drug, pointed the same way. That is about as direct a demonstration as medicine produces: lower the inflammation, lower the events, with the lipid pathway untouched.
This is the legitimate foundation under the whole idea. Chronic low-grade inflammation is associated with cardiovascular disease, type 2 diabetes, and several cancers, and intervening on it changes outcomes.
What the diet trials actually show
The best dietary evidence is for a whole pattern rather than any individual food. A major Spanish trial randomised people at high cardiovascular risk to a Mediterranean diet supplemented with extra-virgin olive oil or nuts, or to a control low-fat diet, and found roughly a 30% reduction in major cardiovascular events over several years.
That trial has had a complicated history — it was retracted and republished after irregularities in how some participants were randomised, with the main findings holding up in the corrected analysis. It remains the most substantial dietary intervention evidence available, and the Mediterranean pattern is also associated with lower levels of inflammatory markers including C-reactive protein and interleukin-6 in trial data.
Beyond that, higher fibre and whole grain intake is associated with lower CRP, and diets high in trans fats, refined carbohydrate, and alcohol are associated with higher inflammatory markers. A scoring system called the Dietary Inflammatory Index has been used to link “more inflammatory” diets to worse outcomes in cohort studies — useful, but worth knowing that it is a score derived from the literature rather than a measurement of anything in a person.
The diet with the best evidence for lowering inflammation is not an elimination diet. It is just a good diet.
— WellnessLife editorial
The supplement claims
Omega-3 is where a crucial distinction gets lost. A trial of high-dose prescription EPA — 4 grams daily — found a significant reduction in cardiovascular events in a specific high-risk population. Two large trials of standard-dose fish oil supplements, the kind sold in supermarkets at around 1 gram, found no cardiovascular benefit in general populations. These results are frequently reported as though they concern the same thing. They do not.
Curcumin, the active compound in turmeric, deserves a more sceptical hearing than it gets. Meta-analyses do report reductions in inflammatory markers, but the trials are small, heterogeneous, and often at high risk of bias. More fundamentally, curcumin is poorly absorbed, rapidly metabolised, and has been identified by medicinal chemists as a compound that produces false positives across many laboratory assays — a review in a major chemistry journal argued it has never been successfully developed into a drug for exactly these reasons. Turmeric in food is a fine thing. High-dose supplements are a considerably weaker proposition than the marketing suggests.
The foods that get blamed without evidence
Several categories are routinely named as inflammatory with little supporting research in people who do not have a specific diagnosed condition.
Nightshades — tomatoes, peppers, aubergines, potatoes — have essentially no human evidence linking them to inflammation. Dairy is, if anything, neutral to mildly anti-inflammatory in meta-analyses, contrary to its reputation. Gluten matters enormously for people with coeliac disease and has little evidence of inflammatory effect in those without it.
The cost of these claims is not neutral. Each elimination narrows the diet, removes fibre and nutrients, makes eating socially harder, and — in a pattern clinicians increasingly recognise — can shade into restriction that becomes difficult to reverse. An eating pattern justified by health but organised around an expanding list of forbidden foods is worth examining carefully.
The levers that are bigger than food
Three non-dietary factors influence inflammatory markers at least as strongly as diet does, and they get a fraction of the attention.
Body fat, particularly visceral fat, is metabolically active tissue that secretes inflammatory signalling molecules directly. Weight loss reliably reduces CRP, and for many people this is the single largest available lever. Sleep deprivation raises inflammatory markers measurably. Exercise lowers them over time, despite — in fact, partly because of — the acute inflammatory response to a session. Smoking raises them substantially.
An anti-inflammatory regime built entirely around what is on the plate is ignoring most of the mechanism.
- Drug trials targeting inflammation directly reduced cardiovascular events without changing cholesterol, establishing inflammation as causal rather than incidental
- A Mediterranean dietary pattern reduced major cardiovascular events by around 30% in the largest dietary trial available
- Higher fibre and whole grain intake is associated with lower C-reactive protein
- High-dose prescription EPA reduced cardiovascular events; standard fish oil supplements did not in large trials
- Curcumin is poorly absorbed and behaves unreliably in laboratory assays, which undermines much of its supplement literature
- Nightshades, dairy, and gluten have little evidence of inflammatory effect in people without a diagnosed condition
- Visceral fat, poor sleep, inactivity, and smoking influence inflammatory markers at least as much as diet
If you have an autoimmune condition
This needs stating separately. Rheumatoid arthritis, lupus, inflammatory bowel disease and similar conditions involve inflammation of a different kind and magnitude from the low-grade process described above. Dietary changes may help symptoms for some people and are worth discussing with a rheumatologist or gastroenterologist — but they are an adjunct, not a treatment, and stopping prescribed medication in favour of a dietary protocol is a genuinely dangerous course that this literature does not support.
The practical takeaway
The anti-inflammatory diet with real evidence behind it is unremarkable: vegetables, fruit, whole grains, legumes, nuts, olive oil, oily fish, not much ultra-processed food or alcohol. It looks like the Mediterranean pattern because that is the pattern that was tested.
What it does not include is a list of banned foods. If an approach to inflammation is defined mainly by what it forbids — and particularly if that list keeps growing — it has left the evidence behind. The research points toward adding things, and toward the unglamorous levers of sleep, movement, and body composition that sit alongside the plate rather than on it.
Sources
- Ridker PM, Everett BM, Thuren T, et al. “Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS).” New England Journal of Medicine, 2017.
- Estruch R, Ros E, Salas-Salvadó J, et al. “Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (PREDIMED).” New England Journal of Medicine, 2018.
- Bhatt DL, Steg PG, Miller M, et al. “Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT).” New England Journal of Medicine, 2019.
- Manson JE, Cook NR, Lee IM, et al. “Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (VITAL).” New England Journal of Medicine, 2019.
- Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. “The essential medicinal chemistry of curcumin.” Journal of Medicinal Chemistry, 2017.
